Hepatocarcinoma Recurrence on the Liver Study - Part2
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Milano Bicocca
About this trial
Rationale for the trial. To evaluate the impact of surgery on hepatocarcinoma recurrence. Thus, to evaluate the impact of different clinical, radiological, histopathological variables on recurrence after surgical treatment. The nature of this study will allow to observe, over time, the distribution of the considered collection variables, allowing a strictly observational monitoring of possible associations able to suggest models or interpretations, which can then be the basis for the construction of prospective and randomized studies.
Eligibility criteria
Qualifiers
No age limit.
Hepatocarcinoma diagnosis confirmed at histological specimen
Every single patients with first HCC diagnosis or with a recurrence/persistence disease evaluated and treated with surgery at the participating center.
the assessment for patient enrollment must have been performed starting from 02/02/2019.
Disqualifiers
Surgery as a downstaging therapy for transplant
Patients treated with surgery in case of not-curative intent (palliation, best supportive care, etc).
Histopathological specimen of combined liver primary neoplasms (e.g. "hepatocholangiocarcinoma'').
Patients with other tumors in the previous past.
Trial design
Treatments tested in this trial
- liver resection
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov